Skeletal muscle and obesity

Handbook of Obesity: Etiology and Pathophysiology, Second Edition

Volumn , Issue , 2003, Pages 733-752

  Kelley, David E ^a   Storlien, Len ^b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84655166224     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (116)

1. Goodpaster BH, Thaete FL, Simoneau J-A, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46:1579–1585.
2. Landin K, Lindgärde F, Saltin B, Wilhelmsen L. Decreased skeletal muscle potassium in obesity. Acta Med Scand 1988; 223:507–513.
3. Ross R, Shaw KD, Rissanen J, Martel Y, De Guise J, Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994; 59:1277–1285.
4. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85:115–122.
5. Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J App Physiol 2000; 89:104–110.
6. Kelley DE, Slasky S, Janosky J. Effects of obesity and non-insulin dependent diabetes mellitus. Am J Clin Nutr 1991; 54:509–515.
7. Simoneau J-A, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997; 83:166–171.
8. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on insulin sensitivity in obesity: Influence of regional adiposity. Diabetes 1999; 48:839–847.
9. Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB, Stamm E, Newman AB. Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol 2001; 90:2157–2165.
10. Kelley DE, Goodpaster BH, Wing RR, Simoneau J-A. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol Endocrinol Metab 1999; 40(277):E1130-E1141.
11. Boesch C, Slotboom J, Hoppeler H, Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 1997; 37:484–493.
12. Szcepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, Mc Garry JD, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 1999; 276:E977-E989.
13. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a *H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48:1600–1606.
14. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000; 71:885–892.
15. Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C, Storlien LH. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 1995; 96:2802–2808.
16. Phillips DW, Caddy S, Llic V, Frayn KN, Borthwick AC, Taylor R. Intramuscular triglycerides and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996; 45:947–950.
17. Wang N, Hikida RS, Staron RS, Simoneau JA. Muscle fiber types of women after resistance training—quantitative ultrastructure and enzyme activity. Pflugers Arch 1993; 424:494–502.
18. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weightloss. Metabolism 1999;49:467–472.
19. Malenfant P, Theriault R, Goodpaster BH, Kelley DE, Simoneau J-A. Fat content in individual muscle fibers of lean and obese subjects. Int J Obes Relat Metab Disord 2001; 25:1316–1321.
20. Hoppeler H, Howald H, Conley K, Lindstedt SL, Claasen H, Vock P, Weibel ER. Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol 1985; 59:320–327.
21. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turdotte LP, Van der Vusse GJ, Glatz JFC. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 1998; 275:E471-E478.
22. Budohoski L, Gorski J, Nazar K, Kaciuba-Uscilko H, Terjung RL. Triacylglycerol synthesis in the different skeletal muscle fiber sections of the rat. Am J Physiol Endocrinol Metab 1996; 271:E574-E581.
23. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, Van der Vusse GJ, Bonen A. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol Endocrinol Metab 1997; 272:E340-E351.
24. He J, Watkins S, Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 2001; 50:817–823.
25. Lillioja S, Young A, Culter C, Ivy J, Abbot W, Zawadzki J, Yki-Järvinen H, Christin L, Secomb T, Bogardus C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987; 80:415–424.
26. Wade A, Marbut M, Round J. Muscle fiber type and aetiology of obesity. Lancet 1990; 335:805–808.
27. Helge JW, Fraser AM, Kriketos AD, Jenkins AB, Calvert GD, Ayre KJ, Storlien LH. Interrelationships between muscle fibre type, substrate oxidation and body fat. Int J Obes Relat Metab Disord 1999; 23:986–991.
28. Krotkiewski M, Seidell JC, Björntorp P. Glucose tolerance and hyperinsulinaemia in obese women: role of adipose tissue distribution, muscle fibre characteristics and androgens. J Int Med 1990; 228:385–392.
29. Simoneau JA, Bouchard C. Skeletal muscle metabolism and body fat content in men and women. Obes Res 1995; 3:23–29.
30. Segal K, Chatr-Aryamontri B, Rosenbaum M, Simoneau JA. Effects of hypertension and obesity on postprandial thermogenesis in men. Am J Clin Nutr 1995; 61:895.
31. Krotkiewski M, Bylund-Fallenius AC, Holm J, Bjorntorp P, Grimby G, Mandroukas K. Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training. Eur J Clin Invest 1983; 13:5–12.
32. Bjorntorp P. Insulin resistance: the consequence of a neuroendocrine disturbance? Int J Obes 1995; 1:S6- S10.
33. Grimby G, Aniansson A, Zetterberg C, Saltin B. Is there a change in relative muscle fibre composition with age? Clin Physiol 1984; 4:189–194.
34. Kriketos AD, Baur LA, O' Conner JO, Carey D, King S, Caterson ID, Storlien LH. Muscle fibre type composition in infant and adult populations and relations with obesity. Int J Obes Relat Metab Disord 1997;21:796–801.
35. Morio B, Hocquette J-F, Moontaurier C, Boirie Y, Bouteloup-Demange C, Mc Cormack C, Fellman N, Beaufrere B, Ritz P. Muscle fatty acid oxidative capacity is a determinant of whole body fat oxidation in elderly people. Am J Physiol Endocrinol Metab 2001; 280:E143-E149.
36. Reichmann H, Pette D. A comparative microphotometric study of succinate dehydrogenase activity levels in type I, IIA and IIB fibres of mammalian and human muscles. Histochemistry 1982; 74:27–41.
37. Hoppeler H. The range of mitochondrial adaptation in muscle fibers. In: Pette D, ed. The Dynamic State of Muscle Fibers. Berlin: Walter de Gruyter, 1990:567–586.
38. Lowry CV, Kimmey JS, Felder S, Chi MM, Kaiser KK, Passonneau PN, Kirk KA, Lowry OH. Enzyme patterns in single human muscle fibers. J Biol Chem 1978; 253:8269–8277.
39. Simoneau J-A, Lortie G, Boulay MR, Thibalt MC, Theriault G, Bouchard C. Skeletal muscle histochemical and biochemical characteristics in sedentary male and female subjects. Can J Physiol Pharmacol 1985; 63:30–35.
40. Gollnick PD, Saltin B. Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin Physiol 1982; 2:1–12.
41. Newsholme EA, Leech AR. Biochemistry for the Medical Sciences. Chicester: John Wiley and Sons, 1983.
42. Simoneau JA, Colberg SR, Thaete FL, Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995; 9:273–278.
43. Kriketos AD, Pan DA, Lillioja S, Cooney GJ, Baur LA, Milner MR, Sutton JR, Jenkins AB, Bogardus C, Storlien LH. Interrelationships between muscle morphology, insulin action, and adiposity. Am J Physiol Endocrinol Metab 1996; 270:R1332-R1339.
44. Colberg SR, Simoneau J-A, Thaete LF, Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 1995; 95:1846–1853.
45. Sun G, Ukkola O, Rankinen T, Joanisse D, Bouchard Skeletal muscle characteristics predict body fat gain in response to overfeeding in never-obese young men. Metabolism 2002; 51:451–456.
46. Ferraro R, Eckel R, Larson E, Fontvielle A, Rising R, Jesnen D, Ravussin E. Relationship between skeletal muscle lipoprotein lipase activity and 24-hour macronutrient oxidation. J Clin Invest 1993; 92:441–445.
47. Zurlo F, Nemeth PM, Choski RM, Sesodia S, Ravussin Whole body energy metabolism and skeletal muscle biochemical characteristics. Metabolism 1994; 43:481–486.
48. Simoneau J-A, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 1999; 13:2051–2060.
49. Blaak EE, Wagenmakers AJM, Glatz JFC, Wolffenbuttel BHR, Kemerink GJ, Langenberg CJM, Heidendal GAK, Saris WHM. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 2000; 279:146–154.
50. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 1999; 276:E1-E18.
51. Winder WW, Arogyasami J, Elayan IM, Cartmill D. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol Endocrinol Metab 1990; 259:E266-E271.
52. Mc Garry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system: from concept to molecular analysis. Eur J Biochem 1997; 224:1–14.
53. Winder WW, Ma Clean PS, Lucas JC, Fernley JE, Trumble GE. Effect of fasting and refeeding on acetyl-CoA carboxylase in rat hindlimb muscle. J Appl Physiol 1995; 78:578–582.
54. Witters LA, Watts TD, Daniels DL, Evans JL. Insulin stimulates the dephosphorylation and activation of acetyl-CoA carboxylase. Proc Natl Acad Sci USA 1988; 85:5473–5477.
55. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, Mc Garry JD. Prolonged inhibition of muscle carnitine palmitoyltransferase-1-promotes intramyo- cellular lipid accumulation and insulin resistance in rats. Diabetes 2001; 50:123–130.
56. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 2000; 279:E554-E560.
57. Oakes ND, Bell KS, Furler SM, Camilleri S, Saha AK, Ruderman NB, Chisholm DJ, Kraegen EW. Diet- induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes 1997; 46:2022–2028.
58. Faergman NJ, Knudsen J. Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and cell signaling. Biochem J 1997; 323:1–12.
59. Nordfors L, Hoffstedt J, Nyberg B, Thorne A, Arner P, Schalling M, Lonnqvist F. Reduced gene expression of UCP2 but not UCP3 in skeletal muscle of human obese subjects. Diabetologia 1998; 41:935–939.
60. Simoneau J-A, Kelley DE, Neverova M, Wardin CH. Overexpression of muscle uncoupling protein-2 content in human obesity associates with reduced skeletal muscle lipid utilization. FASEB J 1998; 12:1739–1745.
61. Boss O, Bobbioni-Harsch E, Assimacopooulos-Jeannet Muzzin P, Murger R, Giacobino J-P, Golay A. Uncoupling protein-3 expression in skeletal muscle and free fatty acids in obesity. Lancet 1998; 351:1933.
62. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relationship between insulin sensitivity and the fatty acid composition of phospholipids of skeletal muscle. N Engl J Med 1993; 328:238–244.
63. Vessby B, Tengblad S, Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994; 37:1044–1050.
64. Manco M, Mingrone G, Greco AV, Capristo E, Gniuli D, De Gaetano A, Gasbarrini G. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 2000; 49:220–224.
65. Storlien LH, Hulbert AJ, Else PL. Polyunsaturated fatty acids, membrane function and diseases such as diabetes and obesity. Curr Opin Clin Nutr Metab Care 1998; 1:559–563.
66. Else PL, Wu BJ. What role for membranes in determining the higher sodium pump molecular activity of mammals compared to ectotherms? J Comp Physiol B 1999; 169:296–302.
67. Matsuo T, Sumida H, Suzuki M. Beef tallow diet decreases beta-adrenergic receptor binding and lipolytic activities in different adipose tissues of rat. Metabolism 1995; 44:1271–1277.
68. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G Cross-talk mechanisms in the development ofinsulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur J Biochem 1999; 266:17–25.
69. Hajduch E, Balendran A, Batty IH, Litherland GJ, Blair AS, Downes CP, Hundal HS. Ceramide impairs the insulin-dependent membrane recruitment ofprotein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 2001; 44:173–183.
70. Hajduch E, Litherland GJ, Hundal HS. Protein kinase B (PKB/Akt): a key regulator of glucose transport? FEBS Lett 2001; 492:199–203.
71. Zeghari N, Vidal H, Younsi M, Ziegler O, Drouin P, Donner M. Adipocyte membrane phospholipids and PPAR-γ expression in obese women: relationship to hyperinsulinemia. Am J Physiol Endocrinol Metab 2000; 279:E736-E743.
72. Zeghari N, Younsi M, Meyer L, Donner M, Drouin P, Ziegler O. Adipocyte and erythrocyte plasma membrane phospholipid composition and hyperinsulinemia: a study in nondiabetic and diabetic obese women. Int J Obes Relat Metab Disord 2000; 24:1600–1607.
73. Kim JK, Kim Y-J, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108:437–446.
74. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of IKKB. Science 2001; 293:1673–1677.
75. Horton JD, Shimomusa I. Sterol regulatory element- binding proteins: activators of cholesterol and fatty acid biosynthesis. CurrOpin Lipidol 1999; 10:143–150.
76. Hannah VC, Ou J, Luong A, Goldstein JL, Brown MS. Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells. J Biol Chem 2001; 276:4365–4372.
77. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajada FP. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288:2379–2381.
78. Andres R, Cader G, Zierler K. The quantitatively minor role of carbohydrate in oxidative metabolism by skeletal muscle in intact man in the basal state. Measurement of oxygen and glucose uptake and carbon dioxide and lactate production in the forearm. J Clin Invest 1956; 35:671–682.
79. Dagenais G, Tancredi R, Zierler K. Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J Clin Invest 1976; 58:421–431.
80. Baltzan M, Andres R, Cader G, Zierler K. Heterogeneity of forearm metabolism with special reference to free fatty acids. J Clin Invest 1962; 41:116–125.
81. Schwarz J, Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lip-olysis, and whole-body fuel selection. J Clin Invest 1995; 96:2735–2743.
82. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50:1612–1617.
83. Zurlo F, Lillioja S, Esposito-DelPuente A, Nyomba BL, Raz I, Saad MF, Swiunburn WC, Knowler WC, Bogardus C, Ravussin E. Low ratio of fat to carbohydrate oxidation as a predictor of weight gain: a study of 24-h RQ. Am J Physiol Endocrinol Metabol 1990; 259:E650-E657.
84. Blaak EE, Van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA, Saris WH. Beta-adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men. Am J Physiol Endocrinol Metabol 1994; 267:E316-E322.
85. Mandarino LJ, Consoli A, Jain A, Kelley DE. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol Endocrinol Metab 1996; 33:E463-E470.
86. Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 1996; 98:2244–2250.
87. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 2001; 2613–2616.
88. Kelley DE, Reilly J, Veneman T, Mandarino LJ. The influence of physiologic hyperinsulinemia on skeletal muscle glucose storage, oxidation and glycolysis in man. Am J Physiol 1990; 258:E923-E929.
89. Kelley DE, Mokan M, Simoneau J-A, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993; 92:93–98.
90. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C. Effect of fat on insulin- stimulated carbohydrate metabolism in normal men. J Clin Invest 1991; 88:960–966.
91. Felber JP, Ferrannini E, Golay A, Meyer H, Thiebaud Curchod B, Maeder E, Jequier E, De Fronzo R. Role of lipid oxidation in the pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 1987; 36:1341–1350.
92. Lillioja S, Bogardus C, Mott D, Kennedy A, Knowler W, Howard B. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J Clin Invest 1985; 75:1106–1115.
93. Randle PJ, Garland PB, Hales CN, Newsholme EA. 1 The glucose fatty acid cycle: its role in insulin insensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i:785–789.
94. Bryson JM, King SE, Burns CM, Baur LA, Swaraj S, Caterson ID. Changes in glucose and lipid metabolism following weight loss produced by a very low calorie diet in obese subjects. Int J Obes 1996; 20:338–345.
95. Valtuena S, Salas-Salvado J, Lorda PG. The respire tory quotient as a prognostic factor in weight-loss rebound. Int J Obes 1997; 21:811–817.
96. Friedman JE, Dohm L, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, Caro JF. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest 1992; 89:701–705.
97. Kempen KPG, Saris WHM, Kuipers H, Glatz JFC, Van der Vusse GJ. Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic h-oxidative capacity and fatty acid bind protein content. Eur J Clin Invest 1998; 28:1030–1037.
98. Amatruda JM, Statt MC, Welle SL. Total and resting energy expenditure in obese women reduced to ideal body weight. J Clin Invest 1993; 92:1236–1242.
99. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995; 332:621–628.
100. Ranneries C, Bulow J, Buemann B, Christensen NJ, Madsen J, Astrup A. Fat metabolism in formerly obese women. Am J Physiol 1998; 274:E155-E161.
101. Turcotte LP, Richter EA, Kiens B. Increased plasma FFA uptake and oxidation during prolonged exercise in trained versus untrained humans. Am J Physiol 1992; 262:E791-E799.
102. Olefsky JM, Farquhar JW, Reaven G. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 1973; 22:507–513.
103. Olefsky JM. Decreased insulin binding to adipocytes and monocytes from obese subjects. J Clin Invest 1976; 57:1165–1172.
104. Bogardus C, Lillioja S, Stone K, Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 1984; 73:1185–1190.
105. Yki-Jarvinen H, Mott D, Young AA, Stone K, Bogardus C. Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle. J Clin Invest 1987; 80:95–100.
106. Rothman DL, Shulman RG, Shulman GI.31P nuclear magnetic resonance measurements ofmuscle glucose-6- phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89:1069–1075.
107. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97:2859–2865.
108. Shulman GI, Rothman D, Jue T, Stein P, De Fronzo R, Shulman R. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin- dependent diabetes by13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322:223–228.
109. Saccomani MP, Bier DM, De Fronzo RA, Cobelli C. A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. Am J Physiol 1996; 270:E170-E185.
110. Bonadonna RC, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, De Fronzo RA. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 1996; 45:915–925.
111. Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Theriault R. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 1996; 97:2705–2713.
112. Kelley DE, William KV, Price JC. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by positron emission tomography. Am J Physiol Endocrinol Metab 1999; 277:E361-E369.
113. Bogardus C, Lillijoa S, Mott D, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol Endocrinol Metab 1985; 248:E286-E291.
114. Evan DJ, Murray R, Kissebah AH. Relationship between skeletal muscle insulin resistance, insulin- mediated glucose disposal, and insulin binding: effects of obesity and body fat topography. J Clin Invest 1984; 74:1515–1525.
115. Kelley DE, Goodpaster BH. Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc 1999; 31:S619-S623.
116. Yki-Jarvinen H, Koivisto VA. Effects of body composition on insulin sensitivity. Diabetes 1983; 32:765–969.